Bridge Creek Capital Management LLC decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,059 shares of the company’s stock after selling 1,120 shares during the quarter. Colgate-Palmolive comprises approximately 2.1% of Bridge Creek Capital Management LLC’s holdings, making the stock its 11th biggest holding. Bridge Creek Capital Management LLC’s holdings in Colgate-Palmolive were worth $4,402,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Public Employees Retirement Association of Colorado increased its stake in Colgate-Palmolive by 12.6% during the 1st quarter. Public Employees Retirement Association of Colorado now owns 152,445 shares of the company’s stock worth $10,116,000 after buying an additional 17,023 shares during the period. Rafferty Asset Management LLC increased its stake in Colgate-Palmolive by 13.6% during the 1st quarter. Rafferty Asset Management LLC now owns 3,411 shares of the company’s stock worth $226,000 after buying an additional 409 shares during the period. Two Sigma Advisers LP increased its stake in Colgate-Palmolive by 464.4% during the 1st quarter. Two Sigma Advisers LP now owns 528,300 shares of the company’s stock worth $35,058,000 after buying an additional 434,689 shares during the period. CIBC World Markets Inc. increased its stake in Colgate-Palmolive by 2.7% during the 1st quarter. CIBC World Markets Inc. now owns 52,177 shares of the company’s stock worth $3,462,000 after buying an additional 1,377 shares during the period. Finally, Weiss Multi Strategy Advisers LLC purchased a new stake in Colgate-Palmolive during the 1st quarter worth $5,281,000. Institutional investors and hedge funds own 76.74% of the company’s stock.

Shares of NYSE:CL traded up $0.60 during trading on Friday, reaching $80.31. 2,963,577 shares of the company’s stock traded hands, compared to its average volume of 4,302,619. The company has a debt-to-equity ratio of 9.40, a current ratio of 0.92 and a quick ratio of 0.59. Colgate-Palmolive has a 12 month low of $58.49 and a 12 month high of $80.99. The company has a 50 day moving average of $77.55 and a 200-day moving average of $73.84. The stock has a market capitalization of $68.86 billion, a P/E ratio of 26.86, a price-to-earnings-growth ratio of 4.63 and a beta of 0.59.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 31st. The company reported $0.74 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.05. Colgate-Palmolive had a net margin of 16.13% and a return on equity of 559.34%. The business had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.78 billion. During the same quarter in the prior year, the firm earned $0.72 EPS. The company’s revenue for the quarter was up .8% compared to the same quarter last year. Equities research analysts predict that Colgate-Palmolive will post 2.96 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend is Thursday, October 22nd. Colgate-Palmolive’s dividend payout ratio is presently 62.19%.

CL has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Colgate-Palmolive from $75.00 to $78.00 and gave the stock a “hold” rating in a research note on Monday, August 3rd. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, July 31st. Royal Bank of Canada reissued a “buy” rating and issued a $88.00 target price on shares of Colgate-Palmolive in a research report on Thursday, July 30th. Finally, Morgan Stanley boosted their target price on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Monday, August 3rd. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $75.27.

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 85,929 shares of the business’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $76.37, for a total transaction of $6,562,397.73. Following the completion of the transaction, the chief executive officer now directly owns 282,097 shares of the company’s stock, valued at approximately $21,543,747.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sally Massey sold 387 shares of the business’s stock in a transaction dated Monday, September 28th. The shares were sold at an average price of $77.30, for a total transaction of $29,915.10. Following the transaction, the insider now directly owns 4,856 shares of the company’s stock, valued at $375,368.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 256,994 shares of company stock valued at $19,678,851. Insiders own 0.78% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: Quiet Period Expirations Explained

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.